CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,663 enrolled
Drug / intervention
INEGYdrug
Likely dose
INEGY 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00724477
NCT00724477N/ACompleted
CompareCT.gov

PRAGMATIC (This is the True Official Title of the Protocol for This Study)

Organon and Co·observational·Posted Jul 29, 2008·Updated Feb 9, 2022

In Brief

An observational study evaluating INEGY for Primary Hypercholesterolemia. Completed, enrolled 1,663 participants.

Detailed Summary

The main objective of this study is to determine the percentage of patients who met the low-density lipoprotein cholesterol (LDL-C) objective with INEGY, that were not under statin monotherapy treatment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Hypercholesterolemia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 29, 2008
Enrollment StartOct 1, 2007
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 17.9 years ago

Interventions

INEGYdrug

Ezetimibe 10mg - Simvastatine 20 mg or 40 mg; Tablet - OD; Patient currently treated for INEGY for at least 4 weeks